Document Detail


Left ventricular geometry in patients with obstructive sleep apnea coexisting with treated systemic hypertension.
MedLine Citation:
PMID:  16439828     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Left ventricular (LV) hypertrophy is a common consequence of systemic hypertension (SH) and obstructive sleep apnea (OSA). However, little is known about the degree of LV involvement in patients with OSA coexisting with treated SH. OBJECTIVES: Our study was designed in order to assess the prevalence of distinct types of LV geometry in treated hypertensive OSA patients. METHODS: PATIENTS: 183 patients with treated SH were enrolled to the study. Group 1 consisted of 38 patients with newly-diagnosed OSA and ineffectively treated SH. The remaining 145 patients with effectively treated SH were divided into three groups: group 2 - 70 patients with newly-diagnosed OSA, group 3 - 31 patients with OSA treated with continuous positive airway pressure (CPAP), and group 4 - 44 patients without OSA. Overnight sleep studies and M-mode echocardiography were performed. RESULTS: LV mass index did not differ between the study groups. Mean values of LV end-diastolic diameter (LVED) were 55.4 +/- 6.8 mm in group 1 and 53.6 +/- 6.9 mm in group 2 and were significantly increased in comparison to subjects treated with CPAP and controls (49.8 +/- 6.8 mm and 50.1 +/- 64.7 mm, respectively; p = 0.001). LVED correlated positively with the apnea-hypopnea index and desaturation index. LV eccentric hypertrophy was the commonest type of LV geometry in newly-diagnosed OSA patients. CONCLUSIONS: The major finding of our study is the predominance of LV eccentric hypertrophy in newly-diagnosed OSA patients. We suggest that a relatively moderate degree of LV involvement in hypertensive OSA patients may depend on the cardioprotective effect of concomitant antihypertensive therapy, ameliorating OSA-dependent neurohumoral abnormalities.
Authors:
Wojciech Myslinski; Hans-Werner Duchna; Kurt Rasche; Manuel Dichmann; Jerzy Mosiewicz; Gerhard Schultze-Werninghaus
Related Documents :
12415228 - Doppler tissue echocardiographic features of cardiac amyloidosis.
10559078 - Echocardiographic predictors of an adverse response to a nifedipine trial in primary pu...
19959248 - Percutaneous closure of perimembranous ventricular septal defect with an amplatzer duct...
12848658 - Echocardiographic features of patients with heart failure who may benefit from biventri...
22563198 - Differences between diffuse and focal autoimmune pancreatitis.
19813068 - The heart in sporadic inclusion body myositis: a study in 51 patients.
Publication Detail:
Type:  Journal Article     Date:  2006-01-26
Journal Detail:
Title:  Respiration; international review of thoracic diseases     Volume:  74     ISSN:  0025-7931     ISO Abbreviation:  Respiration     Publication Date:  2007  
Date Detail:
Created Date:  2007-02-23     Completed Date:  2007-04-17     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0137356     Medline TA:  Respiration     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  176-83     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University School of Medicine, Lublin, Poland. misl@poczta.wprost.pl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use*
Blood Pressure / physiology
Echocardiography
Heart Ventricles / physiopathology,  ultrasonography*
Humans
Hypertension / complications*,  drug therapy,  physiopathology
Male
Middle Aged
Polysomnography
Severity of Illness Index
Sleep Apnea, Obstructive / complications*,  physiopathology,  ultrasonography
Stroke Volume / physiology
Ventricular Function, Left / physiology
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors related to institutionalization among the frail elderly with home-visiting nursing service i...
Next Document:  Cochlear electrode arrays: past, present and future.